Evidence map›Paper›PMID 35417453›Full record

ArticlePLoS neglected tropical diseases2022

Experimental Schistosoma japonicum-induced pulmonary hypertension.

Biruk Kassa, Michael H Lee, Rahul Kumar, Claudia Mickael, Linda Sanders, Rubin M Tuder, Margaret Mentink-Kane, Brian B Graham

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. A mini review on advances in diagnostic techniques forFrontiers in veterinary science · 2026
    Review
  3. Article
  4. Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  5. Article
  6. ExperimentalPulmonary circulation · 2024
    Article
  7. Parasitic lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Biruk KassaDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Michael H LeeDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Rahul KumarDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Claudia MickaelDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.ORCID 0000-0002-1064-311X
Linda SandersDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Rubin M TuderDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Margaret Mentink-KaneBiomedical Research Institute, Rockville, Maryland, United States of America.
Brian B GrahamDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0001-7541-2585
University of California, San Francisco · USUniversity of Colorado Anschutz Medical Campus · USBiomedical Research Institute · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Role of Complement-Driven Pulmonary Vascular Inflammation in PHP01HL152961 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 2020 to 2024
$14.1M
Investigating paclitaxel treatment in a pre-clinical model of Schistosoma-pulmonary hypertensionR01HL135872 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Brian Barkley Graham · 2017 to 2026
$5.1M
The Role of Smooth Muscle Cell Fatty Acid Oxidation in the Pathogenesis of Pulmonary HypertensionF32HL151076 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, MICHAEL HYUNJEAN · 2020 to 2022
$99k
NHLBI NIH HHS F32 HL151076NHLBI NIH HHS P01 HL014985NHLBI NIH HHS P01 HL152961NHLBI NIH HHS R01 HL135872NIAID NIH HHS HHSN272201700014C
6 · The paper itself

Abstract

backgroundSchistosomiasis, a major cause of pulmonary arterial hypertension (PAH) worldwide, is most clearly described complicating infection by one species, Schistosoma mansoni. Controlled exposure of mice can be used to induce Type 2 inflammation-dependent S. mansoni pulmonary hypertension (PH). We sought to determine if another common species, S. japonicum, can also cause experimental PH.

methodsSchistosome eggs were obtained from infected mice, and administered by intraperitoneal sensitization followed by intravenous challenge to experimental mice, which underwent right heart catheterization and tissue analysis.

resultsS. japonicum sensitized and challenged mice developed PH, which was milder than that following S. mansoni sensitization and challenge. The degree of pulmonary vascular remodeling and Type 2 inflammation in the lungs was similarly proportionate. Cross-sensitization revealed that antigens from either species are sufficient to sensitize for intravenous challenge with either egg, and the degree of PH severity depended on primarily the species used for intravenous challenge. Compared to a relatively uniform distribution of S. mansoni eggs, S. japonicum eggs were observed in clusters in the lungs.

conclusionsS. japonicum can induce experimental PH, which is milder than that resulting from comparable S. mansoni exposure. This difference may result from the distribution of eggs in the lungs, and is independent of which species is used for sensitization. This result is consistent with the clearer association between S. mansoni infection and the development of schistosomiasis-associated PAH in humans.

Indexed as

Hypertension, PulmonarySchistosoma japonicumSchistosomiasisAnimalsInflammationMiceSchistosoma mansoni

Identifiers

PMID35417453
PMCPMC9037943
OpenAlexW4223963311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.